Synthesis of cetyl myristoleate and evaluation of its therapeutic efficacy in a murine model of collagen-induced arthritis

Pharmacological Research

Volumn 47, Issue 1, 2003, Pages 43-47

  Hunter Jr , Kenneth W ^a   Gault, Ruth A ^a   Stehouwer, Jeffrey S ^b   Tam Chang, Suk Wah ^b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

Cetyl myristoleate; Collagen induced arthritis; Inflammation; Synthesis

Indexed keywords

ANTIRHEUMATIC AGENT; CETYL MYRISTOLEATE; COLLAGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; MOUSE; MOUSE STRAIN; MULTIPLE DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; TREATMENT OUTCOME;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; MICE; MICE, INBRED DBA; WAXES;

EID: 0037282481     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00239-6     Document Type: Article

References (20)

1. Diehl H.W., May E.L. Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. J. Pharm. Sci. 83:1994;296-299.
2. Edwards A.M. CMO (cerasomol-cis-9-cetyl myristoleate) in the treatment of fibromyalgia: an open pilot study. J. Nutr. Environ. Med. 11:2001;105-111.
3. Calder P.C., Yaqoob P., Thies F., Wallace F.A., Miles E.A. Fatty acids and lymphocyte functions. Br. J. Nutr. 87:2002;S31-S48.
4. Siegal S, Castellan Jr NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. NewYork: McGraw-Hill; 1998, p. 38.
5. Wooley P.H., Luthra H.S., Stuart J.M., David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:1981;688-700.
6. Wooley P.H. Collagen-induced arthritis in the mouse. Methods Enzymol. 162:1988;361-373.
7. Trentham D.E., Townes A.S., Kang A.H. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:1977;857-868.
8. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 283:1980;666-668.
9. DeLustro F., Carlson R.P., Datko L.J., DeLustro B., Lewis A.J. The absence of antibodies to type II collagen in established adjuvant arthritis in rats. Agents Actions. 14:1984;673-679.
10. Kaibara N., Hotokebuchi T., Takagishi K., Katsuki I., Morinaga M., Arita C.et al. Pathogenetic difference between collagen arthritis and adjuvant arthritis. J. Exp. Med. 159:1984;1388-1396.
11. Carlson R.P., Datko L.J., O'Neill-Davis L., Blazek E.M., DeLustro F., Beideman R.et al. Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred Wistar rats. Int. J. Immunopharmacol. 7:1985;811-826.
12. Martínez-Domínguez E., de la Puerta R., Ruiz-Gutiérrez V. Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet. Inflamm. Res. 50:2001;102-106.
13. Ariza-Ariza R., Mestanza-Peralta M., Cardiel M.H. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin. Arthritis Rheum. 27:1998;366-370.
14. Kremer J.M. N-3 fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr. 71:2000;349S-351S.
15. Nordstrom D.C., Honkanen V.E., Nasu Y., Antila E., Friman C., Konttinen Y.T. Alpha-linoleic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol. Int. 14:1995;231-234.
16. Kremer J.M., Lawrence D.A., Petrillo G.F., Litts L.L., Mullaly P.M., Rynes R.I.et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs; clinical and immune correlates. Arthritis Rheum. 38:1995;1107-1114.
17. Lau C.S., Morley K.D., Belch J.J.F. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br. J. Rheumatol. 32:1993;982-989.
18. James M.J., Cleland L.G. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin. Arthritis Rheum. 27:1997;85-97.
19. Grimble R.F. Modification of inflammatory aspects of immune function by nutrients. Nutr. Res. 18:1998;1297-1317.
20. Grimm H., Mayer K., Mayser P., Eigenbrodt E. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br. J. Nutr. 87:2002;S57-S59.